Both in Pharmaceuticals
Briacell Therapeutics vs TransCode Therapeutics
Over the past year BCTX returned −73.3% and RNAZ returned −84.8%; their daily moves had a correlation of 0.01.
BCTX −73.3% RNAZ −84.8%Growth of $1, one year, split-adjusted
| Metric | BCTX | RNAZ |
|---|---|---|
| Price | $3.04 | $1.66 |
| Market cap | $26.5M | $28.1M |
| Today | −8.31% | −4.05% |
| 1 month | −26.2% | +7.4% |
| 6 months | −27.4% | −78.8% |
| Year to date | −57.3% | −75.7% |
| 1 year | −75.6% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $20.5M | $7.7M |
| Dividend yield | — | — |
| Volatility (60d) | 78.1% | 76.1% |
| Short % of float | 9.3% | 8.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).